Skip to main content
. 2016 Mar 24;7(3):e2157. doi: 10.1038/cddis.2015.401

Figure 6.

Figure 6

ARHGAP10-associated pathways in ovarian cancer. (ac) GSEA was performed using TCGA ovarian serous cystadenocarcinoma dataset. The KEGG cell cycle, DNA replication and BER pathways were identified with the strongest association with ARHGAP10-lower expression. (d) Key moderators were determined by western blotting in A2780 and HO-8910 cells. Upper panel, representative results of western blotting; middle and lower panel, protein levels relative to GAPDH. Data were based on at least three independent experiments, and shown as mean±S.D. (*P<0.05, **P<0.01, ***P<0.001)